If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,244.00    9.00 (0.73%)
Bid:
1,236.00
Ask:
1,239.00
Spread: 3.00 (0.243%)
Market Cap: £860.84m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Exercise of Share Options under LTIP

10 Dec 2010 11:13

RNS Number : 7456X
CVS Group plc
10 December 2010
 



10th December 2010

CVS Group plc

("CVS" or the "Company")

Exercise of Share Options

 

CVS, one of the UK's leading providers of veterinary services, announces that on 9 December 2010, two of its directors Simon Innes (Chief Executive) and Paul Coxon (Finance Director) together with Brian Pound a director of CVS (UK) Limited (a wholly owned subsidiary of CVS Group plc) exercised options over in aggregate 194,779 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares") under the 2007/2010 LTIP Option Scheme. Notification was received by the Company yesterday.

 

Application will be made for the new Ordinary Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or about 15 December 2010.

On admission the Company's issued share capital will be 56,495,096 ordinary shares of 0.2 pence each. The total number of voting rights in the Company will be 56,495,096. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

The exercise of options referred to above includes the exercise of options by the following:

Name of option holder

No. of shares being allotted pursuant to exercise of option

Exercise price per share

Percentage of share capital following exercise and on admission of Ordinary Shares (including that of spouses)

Simon Innes

107,317

£0.002

2.04%

Paul Coxon

53,658

£0.002

0.6%

Brian Pound

33,804

£0.002

1.6%

 

 

Contacts:

 

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Brewin Dolphin

Matt Davis / Paul Mason/ Nikki Cooper

 

0845 213 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEAFAEFFAEFFF
Date   Source Headline
3rd Jul 20264:38 pmRNSStandard form for notification of major holdings
1st Jul 20264:53 pmRNSStandard form for notification of major holdings
30th Jun 20264:21 pmRNSStandard form for notification of major holdings
30th Jun 202610:59 amRNSStandard form for notification of major holdings
30th Jun 20267:00 amRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20269:48 amRNSStandard form for notification of major holdings
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.